Common Contracts
4 similar Manufacturing and Supply Agreement contracts
CONFIDENTIAL- CONFIDENCIAL CONFIDENTIAL- CONFIDENCIALManufacturing and Supply Agreement • December 2nd, 2022 • New York
THIS MANUFACTURING AND SUPPLYAGREEMENT dated as of February 2, 2021 (the “Effective Date”) is made by and between PFIZER EXPORT BV with offices at Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Netherlands (hereinafter “Pfizer”) and Fiduprevisora S.A., as the legal representative and administrator of the Autonomous Patrimony of the National Fund for Disaster Risk Management – Subaccount for the mitigation of emergencies COVID -19 (“FNGRD”) acting as instructed by the Director of the National Disaster and Risk Management Unit (UNGRD), (hereinafter “Purchaser”). Purchaser and Pfizer may be referred to herein individually as a “Party” or collectively as the “Parties”. ESTE ACUERDO DE FABRICACIÓN YSUMINISTRO de fecha 2 de febrero de 2021 (la “Fecha Efectiva”) se celebra entre PFIZER EXPORT BV con domicilio en Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Holanda (en adelante, “Pfizer”) y Fiduprevisora S.A. como representante legal y administradora del Patrimonio Autónomo del
CONFIDENTIAL- CONFIDENCIAL CONFIDENTIAL- CONFIDENCIALManufacturing and Supply Agreement • August 14th, 2022 • New York
THIS MANUFACTURING AND SUPPLYAGREEMENT dated as of February 2, 2021 (the “Effective Date”) is made by and between PFIZER EXPORT BV with offices at Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Netherlands (hereinafter “Pfizer”) and Fiduprevisora S.A., as the legal representative and administrator of the Autonomous Patrimony of the National Fund for Disaster Risk Management – Subaccount for the mitigation of emergencies COVID -19 (“FNGRD”) acting as instructed by the Director of the National Disaster and Risk Management Unit (UNGRD), (hereinafter “Purchaser”). Purchaser and Pfizer may be referred to herein individually as a “Party” or collectively as the “Parties”. ESTE ACUERDO DE FABRICACIÓN YSUMINISTRO de fecha 2 de febrero de 2021 (la “Fecha Efectiva”) se celebra entre PFIZER EXPORT BV con domicilio en Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Holanda (en adelante, “Pfizer”) y Fiduprevisora S.A. como representante legal y administradora del Patrimonio Autónomo del
CONFIDENTIAL- CONFIDENCIALManufacturing and Supply Agreement • August 12th, 2021 • New York
THIS MANUFACTURING AND SUPPLYAGREEMENT dated as of February 2, 2021 (the “Effective Date”) is made by and between PFIZER EXPORT BV with offices at Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Netherlands (hereinafter “Pfizer”) and Fiduprevisora S.A., as the legal representative and administrator of the Autonomous Patrimony of the National Fund for Disaster Risk Management – Subaccount for the mitigation of emergencies COVID -19 (“FNGRD”) acting as instructed by the Director of the National Disaster and Risk Management Unit (UNGRD), (hereinafter “Purchaser”). Purchaser and Pfizer may be referred to herein individually as a “Party” or collectively as the “Parties”. WHEREAS, Pfizer Inc. (“Pfizer US”) and BioNTech SE, a company organized and existing under the laws of Germany (“BioNTech”), are collaborating to develop a vaccine to address the global COVID-19 pandemic; WHEREAS, according to the provisions of Law 1523 of 2012, the National Fund for Disaster Risk is a special account
CONFIDENTIAL- CONFIDENCIAL CONFIDENTIAL- CONFIDENCIALManufacturing and Supply Agreement • July 5th, 2021 • New York
THIS MANUFACTURING AND SUPPLYAGREEMENT dated as of February 2, 2021 (the “Effective Date”) is made by and between PFIZER EXPORT BV with offices at Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Netherlands (hereinafter “Pfizer”) and Fiduprevisora S.A., as the legal representative and administrator of the Autonomous Patrimony of the National Fund for Disaster Risk Management – Subaccount for the mitigation of emergencies COVID -19 (“FNGRD”) acting as instructed by the Director of the National Disaster and Risk Management Unit (UNGRD), (hereinafter “Purchaser”). Purchaser and Pfizer may be referred to herein individually as a “Party” or collectively as the “Parties”. WHEREAS, Pfizer Inc. (“Pfizer US”) and BioNTech SE, a company organized and existing under the laws of Germany (“BioNTech”), are collaborating to develop a vaccine to address the global COVID-19 pandemic; WHEREAS, according to the provisions of Law 1523 of 2012, the National Fund for Disaster Risk is a special account
